REGISTRATION > Notice of Registration > Importers Notice of Registration - 2023
Importers Notice of Registration - 2023
IMPORTERS
Effective November 4, 2019, the Importers and Bulk Manufacturer Notices of Registration (NORs) will no longer be published in the Federal Register.
View previously published Federal Register Notices
| File | Registrant | FR Docket | Date |
|---|---|---|---|
| DRG-23-0146 | Cambridge Isotope Laboratories, Inc. | 87 FR 67368 | 11/28/2023 |
| DRG-23-0130 | AndersonBrecon, Inc. DBA PCI Pharma Services |
88 FR 63618 | 11/28/2023 |
| DRG-23-0128 | Experic LLC | 88 FR 63620 | 11/28/2023 |
| DRG-23-0117 | Cambrex High Point, Inc. | 88 FR 63621 | 11/28/2023 |
| DRG-23-0136 | Curia New York, Inc. | 88 FR 63620 | 11/28/2023 |
| DRG-23-0084 | Irvine Labs, Inc. | 88 FR 42104 | 11/28/2023 |
| DRG-22-0156 | Fisher Clinical Services Inc. | 87 FR 62118 | 10/27/2023 |
| DRG-22-0158 | Organic Standards Solutions International, LLC | 87 FR 63101 | 10/27/2023 |
| DRG-22-0142 | VICI Health Sciences, LLC | 87 FR 61367 | 10/27/2023 |
| DRG-23-0109 | ANI Pharmaceuticals Inc. | 88 FR 53926 | 10/27/2023 |
| DRG-23-0112 | Galephar Pharmaceutical Research, Inc. | 88 FR 53923 | 10/27/2023 |
| DRG-23-0107 | Catalent Pharma Solutions, LLC | 88 FR 53923 | 10/27/2023 |
| DRG-23-0119 | Caligor Coghlan Pharma Services | 88 FR 54352 | 10/27/2023 |
| DRG-23-0120 | Cerilliant Corporation | 88 FR 53924 | 10/27/2023 |
| DRG-23-0100 | VICI Health Sciences, LLC | 88 FR 56052 | 10/27/2023 |
| DRG-23-0124 | Curium US LLC | 88 FR 56051 | 10/27/2023 |
| DRG-23-0125 | Catalent CTS, LLC | 88 FR 60498 | 10/27/2023 |
| DRG-23-0131 | Lipomed | 88 FR 60988 | 10/27/2023 |
| DRG-23-0139 | Catalent Greenville, Inc. | 88 FR 60988 | 10/27/2023 |
| DRG-23-0140 | Fisher Clinical Services, Inc. | 88 FR 60499 | 10/27/2023 |
| DRG-22-0160 | VHG Labs dba LGC Standards | 87 FR 76084 | 9/26/2023 |
| DRG-23-0037 | Sigma Aldrich Company LLC | 88 FR 10381 | 9/26/2023 |
| DRG-23-0030 | Meridian Medical Technologies, LLC | 88 FR 17622 | 9/26/2023 |
| DRG-23-0096 | Arizona Department of Corrections | 88 FR 37277 | 9/26/2023 |
| DRG-23-0127 | Chattem Chemicals | 88 FR 54353 | 9/26/2023 |
| DRG-23-0088 | Galephar Pharmaceutical Research, Inc. | 88 FR 33912 | 9/14/2023 |
| DRG-23-0087 | Catalent Greenville, Inc. | 88 FR 37276 | 9/14/2023 |
| DRG-23-0082 | Aurobindo Pharma USA, Inc. | 88 FR 44404 | 9/14/2023 |
| DRG-23-0056 | Restek Corporation | 88 FR 44399 | 9/14/2023 |
| DRG-23-0048 | Caligor Coghlan Pharma Services | 88 FR 17621 | 9/14/2023 |
| DRG-23-0075 | AndersonBrecon Inc. DBA PCI Pharma Services | 88 FR 33913 | 9/14/2023 |
| DRG-23-0090 | Biopharmaceutical Research Company | 85 FR 45926 | 9/14/2023 |
| DRG-23-0069 | United States Pharmacopeial Convention | 88 FR 33915 | 9/14/2023 |
| DRG-23-0080 | VA Cooperative Studies Program | 88 FR 33906 | 9/14/2023 |
| DRG-23-0072 | Royal Emerald Pharmaceuticals | 88 FR 33913 | 9/14/2023 |
| DRG-23-0079 | Unither Manufacturing LLC | 87 FR 61367 | 9/14/2023 |
| DRG-23-0085 | Usona Institute | 88 FR 33912 | 9/14/2023 |
| DRG-23-0091 | Almac Clinical Services Incorp. | 88 FR 33916 | 9/14/2023 |
| DRG-23-0055 | PerkinElmer, Inc. | 88 FR 19327 | 9/14/2023 |
| DRG-23-0023 | Mylan, Inc. | 88 10382 | 9/14/2023 |
| DRG-23-0024 | Globyz Pharma, LLC | 88 FR 5920 | 7/26/2023 |
| DRG-23-0050 | SpecGX LLC | 88 FR 19988 | 6/28/2023 |
| DRG-22-0123 | Bright Green Corporation | 87 FR 48512 | 6/28/2023 |
| DRG-23-0052 | Purisys, LLC | 88 FR 17627 | 6/5/2023 |
| DRG-23-0047 | Lipomed | 88 FR 17623 | 6/5/2023 |
| DRG-23-0049 | Lonza Tampa, LLC | 88 FR 17621 | 6/5/2023 |
| DRG-23-0055 | PerkinElmer, Inc. | 88 FR 19327 | 6/5/2023 |
| DRG-23-0054 | Lyndra Therapeutics | 88 FR 19327 | 6/5/2023 |
| DRG-23-0034 | S&B Pharma LLC | 88 FR 11957 | 4/26/2023 |
| DRG-23-0042 | Stepan Company | 88 FR 11955 | 4/26/2023 |
| DRG-23-0150 | Hybrid Pharma | 87 FR 61364 | 3/30/2023 |
| DRG-23-0013 | VA Cooperative Studies Program | 88 FR 3762 | 3/30/2023 |
| DRG-23-0009 | Noramco | 88 FR 3763 | 3/30/2023 |
| DRG-23-0014 | Siegfried USA, LLC | 88 FR 3762 | 3/30/2023 |
| DRG-23-0022 | Janssen Pharmaceuticals, Inc. | 88 FR 4021 | 3/30/2023 |
| DRG-23-0027 | Medi-Physics Inc. dba GE Healthcare | 88 FR 4022 | 3/30/2023 |
| DRG-23-0026 | Mylan Pharmaceuticals, Inc. | 88 FR 4020 | 3/30/2023 |
| DRG-22-0090 | Aspen API, Inc. | 87 FR 45362 | 1/30/2023 |
| DRG-22-0157 | Nexus Pharmaceuticals | 87 FR 64251 | 1/30/2023 |
| DRG-22-0127 | Curia New York, Inc. | 87 FR 65609 | 1/30/2023 |
| DRG-23-0002 | Mylan Technologies, Inc. | 87 FR 65609 | 1/30/2023 |
| DRG-23-0007 | Lyndra Therapeutics | 87 FR 70860 | 1/30/2023 |
